"Immunology Digest", hosted by Amir Rahmati, breaks down and simplifies the latest research and discoveries in immunology. Whether you're a student, a scientist, or simply curious about the immune system, this podcast offers in-depth insights into the cellular and molecular processes driving immune responses and the latest advancements shaping the field.
Immunology Digest
Claim This Podcastby Immunology Digest
5.0(1 reviews)
5 episodes
Updated Weekly
Accepts GuestsHas Sponsors
Podcast Overview
"Immunology Digest", hosted by Amir Rahmati, breaks down and simplifies the latest research and discoveries in immunology. Whether you're a student, a scientist, or simply curious about the immune system, this podcast offers in-depth insights into the cellular and molecular processes driving immune responses and the latest advancements shaping the field.
Language
🇺🇲
Publishing Since
10/6/2024
Reach the team behind Immunology Digest
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
October 27, 2024
When the Immune System Turns on Bone Marrow: The Role of IFN-γ (Part II)
<p>Link to the study: https://pubmed.ncbi.nlm.nih.gov/26491068/</p>
October 27, 2024
When the Immune System Turns on Bone Marrow: The Role of IFN-γ (Part I)
<p>Link to the study: https://pubmed.ncbi.nlm.nih.gov/26491068/</p>
October 25, 2024
MDSCs in Cancer (Part II)
<p>We continue to discuss a recent study that examines the role of Myeloid-derived Suppressor Cells in cancer and the expression of a receptor, DR-5, as a way to target these cells.</p> <p>Article: Condamine T, Kumar V, Ramachandran IR, et al. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. <em>J Clin Invest</em>. 2014;124(6):2626-2639. doi:10.1172/JCI74056 <a href="https://pubmed.ncbi.nlm.nih.gov/24789911/" rel="ugc noopener noreferrer" target="_blank">https://pubmed.ncbi.nlm.nih.gov/24789911/</a></p>
5 total episodes available
Deep-dive analytics for Immunology Digest
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Immunology Digest?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.